Publications - IR Sant Pau

Search

01/04/2026 Infection and inflammation of the seminal tract: a review of its relationship to male fertility

Suñé, AV, Cosentino, M. Infection and inflammation of the seminal tract: a review of its relationship to male fertility. Actas Urologicas Espanolas. 2026; 50(3)DOI:10.1016/j.acuro.2025.501899. PMID:. IF:1.200(Q3/7D).

01/01/2022 Hemolytic Anemia After Surgical Mitral Valve Repair Treated With Transcatheter Edge-to-Edge Device

Ruiz-López A., Li C.-H.P., Valdovinos P., Rodríguez Á., Bonet A., Tauron M., Ligero C., Millan X., Alegret J.M., Viladés D., Arzamendi D.. Hemolytic Anemia After Surgical Mitral Valve Repair Treated With Transcatheter Edge-to-Edge Device. JACC. Case reports. 2022; 4(12)DOI:10.1016/j.jaccas.2022.03.021. PMID:. IF:(Q/D).

12/05/2024 Prevalence and prognostic significance of malnutrition in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair

Pezzola, E, Tomasoni, D, Caneiro-Queija, B, Raposeiras-Roubin, S, Freixa, X, Arzamendi, D, Benito-González, T, Montefusco, A, Pascual, I, Nombela-Franco, L, Rodes-Cabau, J, Shuvy, M, Portolés-Hernández, A, Godino, C, Haberman, D, Metra, M, Estévez-Loureiro, R, Adamo, M. Prevalence and prognostic significance of malnutrition in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2024; 104(2)DOI:10.1002/ccd.31079. PMID:38736245. IF:2.100(Q3/6D).

01/10/2024 Treatment of functionally nonsignificant vulnerable plaques in multivessel STEMI: design of the VULNERABLE trial

Gomez-Lara, J, Lopez-Palop, R, Rumiz, E, Jurado-Roman, A, Gomez-Menchero, A, Valencia, J, Fernandez, E, Ramirez, LRG, Brugaletta, S, Millan, R, Cortes, C, Tejedor, P, Gutierrez-Barrios, A, Flores, X, Cid-alvarez, AB, Garcia-Blas, S, Garcia-Camarero, T, Vicente, JAL, Vaquerizo, B, Soriano, JGC, Caballero, J, Piris, RMC, Sanchez-Elvira, G, Oyarzabal, L, Pernigotti, A, Tramullas, A, Antuna, P, Rodriguez-Leor, O, Ojeda, S, Rossello, X, Gomez-Hospital, JA, Bermejo, J, Garcia-Garcia, HM, Prado, APD, Gutierrez-Ibanes, E. Treatment of functionally nonsignificant vulnerable plaques in multivessel STEMI: design of the VULNERABLE trial. REC, interventional cardiology. 2024; 6(4)DOI:10.24875/RECIC.M24000468. PMID:. IF:(Q/D).

17/02/2026 Frequency and Prognostic Significance of ESR1 Mutations Post-CDK4/6 inhibitors in ER+/HER2# Metastatic Breast Cancer: Real-World Data from the GEICAM_RegistEM Study

Guerrero-Zotano, A, Antolin, S, Martorell, AT, Cruz-Jurado, J, Andres, R, Saura, S, Rodriguez-Sanchez, C, Galve, E, Falo, C, Margeli-Vila, M, Rodriguez-Lescure, A, Miguel, A, Chacon, J, Adrover-Cebrian, E, Corbellas-Aparicio, M, Marin-Alcala, M, Gonzalez-Maeso, I, Varela-Ferreiro, S, Arqueros, C, Anton-Torres, A, Servitja, S, Moreno-Munoz, D, Merino, M, Ballesteros-Garcia, A, Echarri-Gonzalez, M, Alonso-Romero, J, Seijas, TR, Iranzo-Cruz, V, De la Haba-Rodriguez, J, Guerra, J, Palomar, AL, Illarramendi, MJ, Ortiz, AG, Garcia-Palomo, A, Ruiz-Borrego, M, Villanueva, R, Zazo, S, Jerez-Gilarranz, Y, Rendo, CR, Lizarraga, NA, Ceballos-Lenza, I, Murillo, JL, Figuero, L, Herranz, J, Martin, N, Fernandez-Garcia, D, Lopez, IA, Lopez-Tarruella, S, Todo, FR. Frequency and Prognostic Significance of ESR1 Mutations Post-CDK4/6 inhibitors in ER+/HER2# Metastatic Breast Cancer: Real-World Data from the GEICAM_RegistEM Study. CLINICAL CANCER RESEARCH. 2026; 32DOI:. PMID:. IF:10.200(Q1/1D).

01/03/2026 Impact of Preprocedural Anemia on Outcomes in Patients With Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair: Insights From the TRISPA Registry

Echarte-Morales, J, Ruberti, A, Sanchis, L, Arzamendi, D, Moñivas, V, Carrasco-Chinchilla, FC, Pan, MN, Nombela-Franco, L, Pascual, I, Benito-González, T, Pérez, R, Gómez-Blázquez, I, Amat-Santos, IJ, Cruz-González, I, Sánchez-Recalde, A, Alvarez, ABC, Barreiro-Pérez, M, Umanzor, EF, Li, CH, Trigo, MD, Martínez-Carmona, JD, Mesa, D, Jiménez, P, Cepas-Guillén, P, Avanzas, P, Fernandez-Vázquez, F, Freixa, X, Estévez-Loureiro, R. Impact of Preprocedural Anemia on Outcomes in Patients With Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair: Insights From the TRISPA Registry. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2026; 107(4)DOI:10.1002/ccd.70408. PMID:41398453. IF:2.100(Q3/6D).

01/02/2026 Genetic anticipation and cardiac conduction abnormalities in myotonic dystrophy type 1: implications for early stratification from a multicenter registry

Lorca, R, Alen, A, Moliner-Abos, C, de Frutos, F, Báez-Ferrer, N, Peña-Peña, ML, Villacorta, E, Ripoll-Vera, T, Zorio, E, Martínez-Gimeno, A, Bermudez-Jiménez, J, Limeres, J, Tiron, C, Larrañaga-Moreira, JM, Cabrera-Romero, E, García-Pavia, P, Espinosa, MA, Piqueras, J, García-Hernández, S, Palomino-Doza, J, Soriano-Amores, M, Moris, G, Carrillo-Mora, LM, Syris, P, Alvarez-Velasco, R, Gimeno, JR, Muñoz, C. Genetic anticipation and cardiac conduction abnormalities in myotonic dystrophy type 1: implications for early stratification from a multicenter registry. Ijc Heart & Vasculature. 2026; 62DOI:10.1016/j.ijcha.2025.101851. PMID:41488597. IF:(Q/D).

01/03/2026 Characterization of hepatic, portal, and renal venous flow patterns by Doppler ultrasound across tricuspid regurgitation grades

Rodriguez-Pérez, A, Moliner-Abos, C, Viladés-Medel, D, Fernández-Martinez, J, Mayol-Domingo, J, Ruiz-Lopez, A, Salido, M, Descalzo, M, Pujadas-Olano, S, Menduiña, I, Bos-Real, L, Parada-Barcia, JA, Barreiro-Pérez, M, Forado-Benatar, I, Arenas-Loriente, A, Leta-Petracca, R, Arzamendi, D, Lic, CHP. Characterization of hepatic, portal, and renal venous flow patterns by Doppler ultrasound across tricuspid regurgitation grades. REVISTA ESPANOLA DE CARDIOLOGIA. 2026; 79(3)DOI:10.1016/j.rec.2025.08.002. PMID:40907823. IF:4.900(Q1/2D).

17/02/2026 Long-term response Patterns in HER2-positive advanced breast cancer within the geicam/2014-03 (registem) study

Alvarez, I, Guerrero-Zotano, A, Cruz-Jurado, J, Antol n, S, Galve, E, Rodr guez, C, Hern ndez, M, Tibau, A, Falo, C, Chac n, J, Miguel, A, Rodr guez-Lescure, A, Adrover, E, Margel -Vila, M, Andr s, R, Servitja, S, Merino, M, Gonz lez, I, Alonso-Romero, J, Villanueva, R, Echarri, M, Ant n-Torres, A, Varela, S, Ru z-Borrego, M, Guerra, J, Corbellas, M, Escudero, M, Bezares, S, Rojo, F, L pez-Tarruella, S. Long-term response Patterns in HER2-positive advanced breast cancer within the geicam/2014-03 (registem) study. CLINICAL CANCER RESEARCH. 2026; 32DOI:. PMID:. IF:10.200(Q1/1D).

04/02/2026 Immunological Biomarkers to Assess Activity and Treatment Response in IgG4-Related Disease

Moya-Alvarado, P, Lopez-Gomez, M, Martínez-Martinez, L, Park, HS, Leyva, TF, Martín, MC, Codes-Mendez, H, Lacruz, AC, Calleja, S, Magallares, B, Castellví, I, Barros-Membrilla, AJ, Bernárdez, J, Corominas, H. Immunological Biomarkers to Assess Activity and Treatment Response in IgG4-Related Disease. Medicina-Lithuania. 2026; 62(2)DOI:10.3390/medicina62020323. PMID:41752722. IF:2.400(Q1/3D).

01/02/2026 Urinary sodium to guide diuretic therapy in acute heart failure: results of a national survey

Marcos, MC, Trullàs, JC, Perez-Silvestre, J, Miró, O, Quiroga, B, Mirabet, S, Romero-González, G. Urinary sodium to guide diuretic therapy in acute heart failure: results of a national survey. ESC Heart Failure. 2026; 13(1)DOI:10.1093/eschf/xvag006. PMID:41711714. IF:3.700(Q1/3D).

01/03/2026 Does Biological Sex Determine the Natural History and Management of Infective Endocarditis?

Grillo, S, Isler, B, Bonet-Basiero, A, Roselló-Díez, E, Escolà-Vergé, L. Does Biological Sex Determine the Natural History and Management of Infective Endocarditis?. CANADIAN JOURNAL OF CARDIOLOGY. 2026; 42(3)DOI:10.1016/j.cjca.2025.10.041. PMID:41197950. IF:5.300(Q1/2D).

06/02/2026 Use of anti-nucleocapsid antibody detection as a marker of SARS-CoV-2 infection in healthcare professionals: a longitudinal seroprevalence study at a university hospital in Catalonia, Spain

Micó, M, Trapé, J, González-García, L, Trujillo-Isern, G, González-Fernández, C, López-Madueño, J, Bérgamo, S, Pérez-Vidal, R, Flor, A, Martínez-Montero, R, Rives, J, Arnau, A, Fàbrega, A. Use of anti-nucleocapsid antibody detection as a marker of SARS-CoV-2 infection in healthcare professionals: a longitudinal seroprevalence study at a university hospital in Catalonia, Spain. BMC INFECTIOUS DISEASES. 2026; 26(1)DOI:10.1186/s12879-026-12796-8. PMID:41652586. IF:3.000(Q2/4D).

17/04/2026 N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study

Alonso, M, Popova, E, De Miguel, M, García-Osuna, A, Gonzalez-Tallada, A, Ordoñez-Llanos, J, Jauregui, A, Trujillo, JC, Grande, AM, Martínez-Téllez, E, Parera, A, Planas, G, Trujillo, L, Butron, D, Solà-Roca, J, De Nadal, M. N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study. BMJ Open. 2026; 16(4)DOI:10.1136/bmjopen-2025-108073. PMID:41997702. IF:2.300(Q2/3D).

07/04/2026 Altered small dense LDL profiles in long-standing controlled type 1 diabetes

Sardà, H, Solé, A, Colom, C, Borràs, C, Carreras, G, Benítez, S, Miñambres, I, Escolà-Gil, JC, Sánchez-Quesada, JL, Pérez, A. Altered small dense LDL profiles in long-standing controlled type 1 diabetes. Frontiers in Endocrinology. 2026; 17DOI:10.3389/fendo.2026.1804987. PMID:42022901. IF:4.600(Q1/3D).

27/04/2026 Why does LDL-C follow a different paradigm from other endocrine-metabolic diseases in cardiovascular prevention?

Sánchez-Quesada, JL, Pérez, A. Why does LDL-C follow a different paradigm from other endocrine-metabolic diseases in cardiovascular prevention?. Frontiers in Endocrinology. 2026; 17DOI:10.3389/fendo.2026.1813342. PMID:42125229. IF:4.600(Q1/3D).

20/01/2026 Cardiovascular biomarkers and preeclampsia: A narrative review

Ullmo, J, Nan, MN, Cruz-Lemini, M, Garrido-Gimenez, C, Platero, J, García-Osuna, A, García-Manau, P, Twickler, M, Llurba, E. Cardiovascular biomarkers and preeclampsia: A narrative review. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56(1)DOI:10.1111/eci.70123. PMID:41059676. IF:3.600(Q1/2D).

01/10/2024 PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia.

Borràs C, Canyelles M, Girona J, Ibarretxe D, Santos D, Revilla G, Llorente-Cortes V, Rotllan N, Kovanen PT, Jauhiainen M, Lee-Rueckert M, Masana L, Arrieta F, Martínez-Botas J, Gómez-Coronado D, Ribalta J, Tondo M, Blanco-Vaca F, Escolà-Gil JC. PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia.. Jacc-Basic To Translational Science. 2024; 9(10)DOI:10.1016/j.jacbts.2024.06.008. PMID:39534644. IF:(Q/D).

01/08/2024 Exploring Plasma Coenzyme Q₁₀ Status in Paediatric Dyslipidaemia

Minguez, B, de Los Santos, M, Garcia-Volpe, C, Molera, C, Paredes-Fuentes, AJ, Oliva, C, Arias, A, Rodriguez-Gonzalez, H, Yubero, D, Tondo, M, Santos-Ocaña, C, Meavilla, S, Artuch, R. Exploring Plasma Coenzyme Q₁₀ Status in Paediatric Dyslipidaemia. Antioxidants. 2024; 13(8)DOI:10.3390/antiox13080966. PMID:39199213. IF:6.600(Q1/1D).

01/05/2026 Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study

Garcia-Pagan, JC, Gluud, LL, Mandorfer, M, Schattenberg, JM, De Gottardi, A, Berzigotti, A, Fortea, JI, Martínez, AA, Alvarado-Tapias, E, Berning, M, Petryszyn, P, Henricson, E, Berglind, N, Lin, M, Persson, K, Mercier, A, Ambery, P, Bosch, J, Oscarsson, J, Rockey, DC. Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; 92(5)DOI:10.1002/bcp.70332. PMID:41362018. IF:3.000(Q2/4D).

01/04/2026 Trends in incidence, prevalence, and survival of primary liver cancer in the United Kingdom (2000-2021)

Cuyàs, B, Alvarado-Tapias, E, Tan, EH, Golozar, A, Duarte-Salles, T, Delmestri, A, Argemi, J, Man, WY, Burn, E, Guarner-Argente, C, Alhambra, DP, Newby, D. Trends in incidence, prevalence, and survival of primary liver cancer in the United Kingdom (2000-2021). EUROPEAN JOURNAL OF PUBLIC HEALTH. 2026; 36(2)DOI:10.1093/eurpub/ckaf153. PMID:41212072. IF:3.900(Q1/2D).

01/11/2024 Strategies for the prevention and non-pharmacological treatment of obesity. Models of care

Rosales, A, Mendoza, L, Minambres, I. Strategies for the prevention and non-pharmacological treatment of obesity. Models of care. Atencion Primaria. 2024; 56(11)DOI:10.1016/j.aprim.2024.102978. PMID:38820670. IF:1.600(Q2/4D).

01/08/2025 Characterizing the clinical profile and prevalence of people with diabetes attended in the hospital setting by using unstructured healthcare data and natural language processing: the Diabetic@ study

Blanco-Carrasco, AJ, Merino-Torres, JF, Almanza, MR, Molina, GC, Brito-Sanfiel, MA, Galindo, DEB, Olmedo, LAC, Mauricio, D, Povedano, ST, Barro, JAB, Sánchez, JJA, Mutiozabal, MS, Pimentel, B, Domínguez, AP, Arias-Cabrales, C, Fanjul, V, de Isla, LP, González, JFN. Characterizing the clinical profile and prevalence of people with diabetes attended in the hospital setting by using unstructured healthcare data and natural language processing: the Diabetic@ study. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 226DOI:10.1016/j.diabres.2025.112214. PMID:40319920. IF:7.400(Q1/1D).

01/01/2026 Implementation of a Personalized Medicine Approach in Patients With Type 2 Diabetes Mellitus Receiving Multiple Daily Insulin Injections (POMA Project): Protocol for a Before-and-After Intervention Study (vol 15, e95267, 2026)

Giné-Balcells, R, Vlacho, B, Vidal-Pérez, OC, Lecub, A, Franch-Nadal, J, Mauricio, D, Molló-Iniesta, A, Hernández, M. Implementation of a Personalized Medicine Approach in Patients With Type 2 Diabetes Mellitus Receiving Multiple Daily Insulin Injections (POMA Project): Protocol for a Before-and-After Intervention Study (vol 15, e95267, 2026). Jmir Research Protocols. 2026; 15DOI:10.2196/95267. PMID:. IF:(Q/D).

18/11/2025 Deciphering the association between morphological differences in hypothalamic subregions and circulating ghrelin and leptin concentrations: exploratory evidence in anorexia nervosa and obesity

Collantoni, E, Miranda-Olivos, R, Ugur, S, Baenas, I, Tovar, S, Dieguez, C, Vilarrasa, N, Lopez-Urdiales, R, Guerrero-Pérez, F, Jiménez-Murcia, S, Soriano-Mas, C, Fernández-Aranda, F. Deciphering the association between morphological differences in hypothalamic subregions and circulating ghrelin and leptin concentrations: exploratory evidence in anorexia nervosa and obesity. Translational Psychiatry. 2025; 15(1)DOI:10.1038/s41398-025-03708-6. PMID:41253760. IF:6.200(Q1/1D).

Giné-Balcells, R, Vlacho, B, Vidal-Pérez, OC, Lecube, A, Franch-Nadal, J, Mauricio, D, Molló-Iniesta, A, Hernández, M. Implementation of a Personalized Medicine Approach in Patients With Type 2 Diabetes Mellitus Receiving Multiple Daily Insulin Injections (POMA Project): Protocol for a Before-and-After Intervention Study. Jmir Research Protocols. 2026; 15DOI:10.2196/85375. PMID:41734338. IF:(Q/D).

01/07/2025 Pregnancy outcomes with the pregestational use of Minimed 780G compared to Minimed 640G: findings from a multicenter cohort study

Perea, V, Quirós, C, Herrera-Arranz, MT, Azriel-Mira, S, Wägner, AM, Beato-Vibora, P, Soldevila, B, Barquiel, B, Pardo, RM, Díaz-Soto, G, Picón, MJ, Colomo, N, Amigó, J, Climent, E, Durán-Martínez, M, Corcoy, R, Codina, M, Cuesta, M, Guedes, BV, Vinagre, I. Pregnancy outcomes with the pregestational use of Minimed 780G compared to Minimed 640G: findings from a multicenter cohort study. ACTA DIABETOLOGICA. 2025; 62(7)DOI:10.1007/s00592-024-02430-x. PMID:39630235. IF:2.900(Q3/6D).

03/11/2025 HFpEF as the predominant and underrecognized heart failure phenotype in type 2 diabetes: evidence from the DIABET-IC study

Gil-Millan, P, Gimeno-Orna, JA, Rodriguez-Padial, L, Muniz, J, Barrios, V, Anguita, M, Perez, A. HFpEF as the predominant and underrecognized heart failure phenotype in type 2 diabetes: evidence from the DIABET-IC study. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02995-z. PMID:41185008. IF:10.600(Q1/1D).

01/10/2025 Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis

Romero-Gómez, M, Escalada, J, Noguerol, M, Pérez, A, Carretero, J, Crespo, J, Mascort, JJ, Aguilar, I, Tinahones, F, Canones, P, Gómez-Huelgas, R, de Luis, D, Trullos, IG, Aller, R, Rubio, MA. Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis. Gastroenterologia y Hepatologia. 2025; 48(8)DOI:10.1016/j.gastrohep.2025.502442. PMID:40221023. IF:1.900(Q3/7D).

01/02/2025 Glycemic and weight control in people with type 2 diabetes: A real-world observational study in primary care

Orozco-Beltran, D, Mata-Cases, M, Artola-Menéndez, S, Alvarez-Guisasola, F, Cebrián-Cuenca, A, Pérez, A. Glycemic and weight control in people with type 2 diabetes: A real-world observational study in primary care. Primary Care Diabetes. 2025; 19(1)DOI:10.1016/j.pcd.2024.12.002. PMID:39741072. IF:2.300(Q2/5D).

01/08/2025 Lack of Validity of the Glucose Management Indicator in Type 1 Diabetes in Pregnancy

Meek, CL, Feig, DS, Scott, EM, Corcoy, R, Murphy, HR, CONCEPTT Collaborat Grp. Lack of Validity of the Glucose Management Indicator in Type 1 Diabetes in Pregnancy. DIABETES CARE. 2025; 48(8)DOI:10.2337/dc24-2494. PMID:40173096. IF:16.600(Q1/1D).

01/01/2025 Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome

Magaz, M, Giudicelli-Lett, H, Abraldes, JG, Nicoara-Farcau, O, Turon, F, Rajoriya, N, Goel, A, Raymenants, K, Hillaire, S, Téllez, L, Elkrief, L, Procopet, B, Orts, L, Nery, F, Shukla, A, Larrue, H, Degroote, H, Aguilera, V, Llop, E, Turco, L, Indulti, F, Gioia, S, Tosetti, G, Bitto, N, Becchetti, C, Alvarado, E, Roig, C, Diaz, R, Praktiknjo, M, Konicek, AL, Olivas, P, Fortea, JI, Masnou, H, Puente, A, Ardèvol, A, Navascués, CA, Romero-Gutiérrez, M, Scheiner, B, Semmler, G, Mandorfer, M, Damiao, F, Baiges, A, Ojeda, A, Simón-Talero, M, González-Alayón, C, Díaz, A, García-Criado, A, De Gottardi, A, Hernández-Guerra, M, Genescà, J, Drilhon, N, Ferreira, CN, Reiberger, T, Rodríguez, M, Morillas, RM, Crespo, J, Trebicka, J, Bañares, R, Villanueva, C, Berzigotti, A, Primignani, M, La Mura, V, Riggio, O, Schepis, F, Verhelst, X, Calleja, JL, Bureau, C, Albillos, A, Nevens, F, Hernández-Gea, V, Tripathi, D, Rautou, PE, García-Pagán, JC. Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome. JOURNAL OF HEPATOLOGY. 2025; 82(1)DOI:10.1016/j.jhep.2024.07.035. PMID:39181213. IF:33.000(Q1/1D).

01/11/2024 Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD

Paternostro, R, Kwanten, WJ, Hofer, BS, Semmler, G, Bagdadi, A, Luzko, I, Hernández-Gea, V, Graupera, I, García-Pagán, JC, Saltini, D, Indulti, F, Schepis, F, Moga, L, Rautou, PE, Llop, E, Téllez, L, Albillos, A, Fortea, JI, Puente, A, Tosetti, G, Primignani, M, Zipprich, A, Vuille-Lessard, E, Berzigotti, A, Taru, MG, Taru, V, Procopet, B, Jansen, C, Praktiknjo, M, Gu, WY, Trebicka, J, Ibanez-Samaniego, L, Bañares, R, Rivera-Esteban, J, Pericas, JM, Genesca, J, Alvarado, E, Villanueva, C, Larrue, H, Bureau, C, Laleman, W, Ardevol, A, Masnou, H, Vanwolleghem, T, Trauner, M, Mandorfer, M, Francque, S, Reiberger, T. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD. JOURNAL OF HEPATOLOGY. 2024; 81(5)DOI:10.1016/j.jhep.2024.05.033. PMID:38823501. IF:33.000(Q1/1D).

01/06/2025 Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study

Ukashi, O, Amiot, A, Laharie, D, Menchen, L, Gutierrez, A, Fernandes, S, Pessarelli, T, Correia, F, Gonzalez-Munoza, C, Lopez-Cardona, J, Calabrese, G, Ferreiro-Iglesias, R, Tamir-Degabli, N, Dussias, NK, Mousa, A, Oliveira, R, Richard, N, Veisman, I, Sharif, K, Ben-Horin, S, Soutullo-Castineiras, C, Dragoni, G, Rotulo, S, Favale, A, Calmejane, L, Bazin, T, Elosua, A, Lopes, S, Felice, C, Mauriz, V, Rodrigues, IC, Jougon, J, Botto, I, de Sousa, HT, Bertani, L, Abadia, PR, De Bernardi, A, Zabana, Y, Serra-Ruiz, X, Viola, A, Acosta, MBD, Yanai, H, Armuzzi, A, Magro, F, Kopylov, U. Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study. United European Gastroenterology Journal. 2025; 13(5)DOI:10.1002/ueg2.12757. PMID:39825768. IF:6.700(Q1/2D).

01/11/2025 Addition of pulse corticosteroids to oral prednisone in moderately active ulcerative colitis: a randomized, multicentre, open-label study by GETECCU

Llao, J, Mañosa, M, Martín-Arranz, E, Zabana, Y, Navarro-Llavat, M, Téller, M, Garcia-Planella, E, Busquets, D, Monfort, D, Pineda, JR, Gutiérrez, A, Villoria, A, Menchén, L, Bastida, G, García-Alonso, FJ, Rivero, M, Chaparro, M, de Francisco, R, Merino, O, Rodríguez-Lago, I, Acosta, MBD, Rodríguez-Fortúnez, P, Rodríguez-Jiménez, C, Calafat, M, Domènech, E. Addition of pulse corticosteroids to oral prednisone in moderately active ulcerative colitis: a randomized, multicentre, open-label study by GETECCU. Journal of Crohns & Colitis. 2025; 19(11)DOI:10.1093/ecco-jcc/jjaf182. PMID:41258993. IF:8.700(Q1/1D).

14/04/2026 REACT Score, a Novel Scoring System, Improves the Prediction of Non-Elective Readmissions in Patients With Decompensated Cirrhosis

Sánchez-Torrijos, Y, Torres-Domínguez, A, Carmona, I, Ibáñez-Samaniego, L, Román, E, Casado, M, García-Cortés, M, Jimeno, C, Rosales-Zabal, JM, Fernández-Alvarez, P, Sendra, C, López-Garrido, A, Ballester, MP, Rodríguez-Perálvarez, M, Estévez, M, García-García, A, Jiménez-Pérez, M, del Pino, P, Santamaría, G, Sánchez, J, Zamora, J, Rodríguez, M, Castillo, L, Aguilera, V, Romero, G, Reddy, KR, Romero-Gómez, M, Ampuero, J. REACT Score, a Novel Scoring System, Improves the Prediction of Non-Elective Readmissions in Patients With Decompensated Cirrhosis. LIVER INTERNATIONAL. 2026; 46(5)DOI:10.1111/liv.70639. PMID:41981917. IF:5.200(Q1/2D).

01/04/2026 Closing the sex and gender gap in clinical practice: recommendations from the Catalan Society of Health with a Sex and Gender Perspective. The GENDERCARE decalogue

Coll-Vinent, B, Borràs, A, Escorsell, A, Comas, C. Closing the sex and gender gap in clinical practice: recommendations from the Catalan Society of Health with a Sex and Gender Perspective. The GENDERCARE decalogue. European Journal of Emergency Medicine. 2026; 33(2)DOI:10.1097/MEJ.0000000000001312. PMID:41557155. IF:4.200(Q1/1D).

01/04/2025 Peroral endoscopic myotomy (POEM) as a treatment for pediatric achalasia: multicenter study and first results

Villanueva, CL, Arbizu, EA, Goruppi, I, Lozano, NB, Bianchi, F, Martínez, AP, Pina, SM, Caballero, AYM, Murzi, M, Betroletti, F, Estremera, F, Guerrero, SB, Argente, CG. Peroral endoscopic myotomy (POEM) as a treatment for pediatric achalasia: multicenter study and first results. Gastroenterologia y Hepatologia. 2025; 48(4)DOI:10.1016/j.gastrohep.2024.502262. PMID:39343296. IF:1.900(Q3/7D).

01/05/2026 Antithrombotic and management of small bowel bleeding - time to throw caution into the wind?

Scaramella, L, Cosenza, A, Romero-Mascarell, C, Elli, L. Antithrombotic and management of small bowel bleeding - time to throw caution into the wind?. CURRENT OPINION IN GASTROENTEROLOGY. 2026; 42(3)DOI:10.1097/MOG.0000000000001160. PMID:41700996. IF:2.500(Q2/5D).

01/04/2022 Implementing a fast-track TAVI pathway in times of COVID-19: necessity or opportunity?

Asmarats, L, Millan, X, Cubero-Gallego, H, Valverde, J, Li, CH, Arzamendia, D. Implementing a fast-track TAVI pathway in times of COVID-19: necessity or opportunity?. REC, interventional cardiology. 2022; 4(2)DOI:10.24875/RECICE.M22000269. PMID:. IF:(Q/D).

01/11/2024 Transcatheter Aortic Valve Replacement: Latest Advances and Prospects

Asmarats, L, Arzamendi, D. Transcatheter Aortic Valve Replacement: Latest Advances and Prospects. Journal of Clinical Medicine. 2024; 13(21)DOI:10.3390/jcm13216583. PMID:39518721. IF:2.900(Q1/2D).

02/05/2024 Targeting confluent areas of slow conduction and electrogram fragmentation for atrioventricular node re-entrant tachycardia ablation

Jiménez-López, J, Bazan, V, Gonzalez-Matos, CE, Di Marco, A, Bottoni, N, Battista, A, Giacoman, S, Sanchez-Millán, PJ, Lozano, JM, Alvarez-López, M, Belarte-Tornero, LC, Anguera, I, Casteigt, BJ, Sarrias-Mercé, A, Weidmann, ZM, Alonso-Martín, C, Llorca, L, Vallés-Gras, E. Targeting confluent areas of slow conduction and electrogram fragmentation for atrioventricular node re-entrant tachycardia ablation. EUROPACE. 2024; 26(5)DOI:10.1093/europace/euae094. PMID:38606815. IF:7.400(Q1/2D).

01/01/2024 Usefulness of Antigen Carbohydrate 125 and N-Terminal Pro-B-Type Natriuretic Peptide for Assessing Congestion in Chronic Heart Failure: Insights from the CARDIOREN Registry

Ordás, JG, Nuñez, J, Claret, RB, Llacer, P, Zegri-Reiriz, I, de la Espriella, R, Fort, A, Rubio-Gracia, J, Blazquez-Bermejo, Z, Mendez, A, Ponz, I, Chaverri, AR, Caravaca-Pérez, P, Mayoral, A, Rubio, CJ, Pomares, A, Soler, MJ, Fluviá, P, Magallón, BG, Górriz, JL, Manzano, L, Husain-Syed, F, Marcos, MC. Usefulness of Antigen Carbohydrate 125 and N-Terminal Pro-B-Type Natriuretic Peptide for Assessing Congestion in Chronic Heart Failure: Insights from the CARDIOREN Registry. CardioRenal Medicine. 2024; 14(1)DOI:10.1159/000541324. PMID:39236691. IF:2.900(Q2/3D).

01/07/2025 Left atrial appendage occlusion plus oral anticoagulation in stroke patients despite ongoing anticoagulation: rationale and design of the ADD-LAAO clinical trial

Amaro, S, Cruz-González, I, Estévez-Loureiro, R, Millan, X, Nombela-Franco, L, Gómez-Hospital, J, Flores-Umanzor, E, López-Mesonero, L, Maciñeira, J, Prats-Sánchez, L, Simal, P, Cardona, P, Teruel, L, Cepas-Guillén, P, Arzamendi, D, Freixa, X. Left atrial appendage occlusion plus oral anticoagulation in stroke patients despite ongoing anticoagulation: rationale and design of the ADD-LAAO clinical trial. REC, interventional cardiology. 2025; 7(3)DOI:10.24875/RECIC.M25000530. PMID:40933018. IF:(Q/D).

01/09/2025 Management of Kidney Disease in Heart Transplant Patients: A National Delphi Survey-based Consensus Expert Paper

García-Cosío Carmena, MD, Farrero, M, Blasco Peiró, MT, Crespo, M, Delgado Jiménez, J, Díaz Molina, B, Fernández Rivera, C, Garrido Bravo, IP, López Jiménez, V, Melilli, E, Mirabet Pérez, S, Pérez Tamajón, ML, Rangel Sousa, D, Rodrigo, E, Cruzado, JM, Hernández Marrero, D. Management of Kidney Disease in Heart Transplant Patients: A National Delphi Survey-based Consensus Expert Paper. TRANSPLANTATION. 2025; 109(9)DOI:10.1097/TP.0000000000005302. PMID:39928546. IF:5.000(Q1/1D).

26/09/2025 Caspase-3 in Brain Death Donors Is Associated with Reduced Primary Graft Dysfunction After Heart Transplantation

Herrador, L, González-Costello, J, Niubo-Bosch, J, Calatayud-Samper, L, Maestro-Benedicto, A, Farrero-Torres, M, Blasco-Peiro, T, Almenar-Bonet, L, Blázquez-Bermejo, Z, Garrido-Bravo, I, Gran-Ipiña, F, Grande-Trillo, A, Manito, N, Moreno-Gonzalez, G. Caspase-3 in Brain Death Donors Is Associated with Reduced Primary Graft Dysfunction After Heart Transplantation. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(19)DOI:10.3390/ijms26199434. PMID:41096699. IF:4.900(Q1/3D).

01/10/2024 Effect of Moderate Beer Intake on the Lipid Composition of Human Red Blood Cell Membranes

López-Yerena, A, Muñoz-García, N, Villaplana, VD, Padro, T, Badimon, L. Effect of Moderate Beer Intake on the Lipid Composition of Human Red Blood Cell Membranes. Nutrients. 2024; 16(20)DOI:10.3390/nu16203541. PMID:39458535. IF:5.000(Q1/2D).

01/01/2025 Restoring cholesterol efflux in vascular smooth muscle cells transitioning into foam cells through Liver X receptor activation

Borràs C., Rotllan N., Griñán R., Santos D., Solé A., Dong C., Zhao Q., Llorente-Cortes V., Mourín M., Soto B., Camacho M., Tondo M., Canyelles M., Blanco-Vaca F., Escolà-Gil J.C.. Restoring cholesterol efflux in vascular smooth muscle cells transitioning into foam cells through Liver X receptor activation. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2025; 188DOI:10.1016/j.biopha.2025.118178. PMID:40403381. IF:(Q/D).

01/06/2025 The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery

Videla, L, Benejam, B, Barroeta, I, Fernandez, S, Altuna, M, Arranz, J, Rodríguez-Baz, I, Arriola-Infante, JE, Maure-Blesa, L, Soriano, LD, Illán-Gala, I, Estellés, T, Sanjuan, A, Vaqué-Alcázar, L, Aranha, MR, Morcillo-Nieto, AO, Zsadanyi, SE, Franquesa-Mullerat, M, Valldeneu, S, Sánchez-Saudinós, MB, Padilla, C, Carreras, M, Lorente, O, Valle-Tamayo, N, Sánchez-Aced, E, Dols-Icardo, O, Sirisi, S, Muñoz, L, Torres, S, El Bennadi, SE, Sánchez, O, Garzón, D, Ribas, L, Elbachiri, S, Mota, C, Tondo, M, Camacho, V, Giménez, S, Delaby, C, Belbin, O, Iulita, MF, Montal, V, Pegueroles, J, Vilaplana, E, Clarimon, J, Gonzalez-Ortiz, S, Molina-Porcel, L, Aldecoa, I, Alcolea, D, Bejanin, A, Videla, S, Blesa, R, Lleo, A, Carmona-Iragui, M, Fortea, J. The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70259. PMID:40528282. IF:11.100(Q1/1D).

01/07/2024 Apolipoproteins in Health and Disease

Ordóñez-Llanos, J, Escolà-Gil, JC. Apolipoproteins in Health and Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(13)DOI:10.3390/ijms25137048. PMID:39000153. IF:4.900(Q1/3D).

01/03/2024 Clinical and outcome comparison of genetically positive vs. negative patients in a large cohort of suspected familial hypocalciuric hypercalcemia

Asla, Q, Sarda, H, Segui, N, de Pinillos, GM, Mazarico-Altisent, I, Capel, I, Rives, J, Suarez, J, avila-Rubio, V, Torres, MM, Saigi, I, Palacios, N, Urgell, E, Webb, SM, Fernandez, M, Oriola, J, Mora, M, Tondo, M, Aulinas, A. Clinical and outcome comparison of genetically positive vs. negative patients in a large cohort of suspected familial hypocalciuric hypercalcemia. ENDOCRINE. 2024; 83(3)DOI:10.1007/s12020-023-03560-y. PMID:38214877. IF:2.900(Q2/5D).

16/07/2024 Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort-the DIABET-IC study

Gonzalez-Manzanares, R, Anguita-Gámez, M, Muñiz, J, Barrios, V, Gimeno-Orna, JA, Pérez, A, Rodríguez-Padial, L, Anguita, M. Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort-the DIABET-IC study. Cardiovascular Diabetology. 2024; 23(1)DOI:10.1186/s12933-024-02358-0. PMID:39014420. IF:10.600(Q1/1D).

01/04/2026 A Real-World Study Comparing Advanced Hybrid Closed-Loop Systems During Pregnancy in Women with Type 1 Diabetes

Quirós, C, Wägner, AM, Azriel, S, Soldevila, B, Beato-Vibora, PI, Arranz, MH, Nattero, L, Picón-Cesar, MJ, Climent, E, Amigó, J, Colomo, N, Durán-Martinez, M, Buesa, MA, Megia, A, Vinagre, I, Guedes, BV, Diaz-Soto, G, Bandres, O, Barquiel, B, Tinocco, CL, Márquez-Pardo, R, Martinez-Brocca, MA, Corcoy, R, Codina, M, Piedra, M, Román, AR, Cuesta, M, López-Gallardo, G, Canino, MMG, Bugatto, F, Mendoza, LC, Márquez, MDO, Perea, V. A Real-World Study Comparing Advanced Hybrid Closed-Loop Systems During Pregnancy in Women with Type 1 Diabetes. Diabetes Technology & Therapeutics. 2026; 28(4)DOI:10.1177/15209156251379488. PMID:41005768. IF:6.300(Q1/2D).

01/05/2026 Baseline and 4-year associations between prediabetes and kidney impairment: Insights from the ILERVAS cohort

Izarra, A, Bermúdez-López, M, Valdivielso, JM, Pamplona, R, Torres, G, Mauricio, D, Castro-Boqué, E, Fernández, E, Simó, R, Hernández, C, Lecube, A. Baseline and 4-year associations between prediabetes and kidney impairment: Insights from the ILERVAS cohort. DIABETES OBESITY & METABOLISM. 2026; 28(5)DOI:10.1111/dom.70560. PMID:41705635. IF:5.700(Q1/2D).

15/04/2024 The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

Ampuero, J, Aller, R, Gallego-Durán, R, Crespo, J, Calleja, JL, García-Monzón, C, Gómez-Camarero, J, Caballería, J, Lo Iacono, O, Ibañez, L, García-Samaniego, J, Albillos, A, Francés, R, Fernández-Rodríguez, C, Maya-Miles, D, Diago, M, Poca, M, Andrade, RJ, Latorre, R, Jorquera, F, Morillas, RM, Escudero, D, Hernández-Guerra, M, Pareja-Megia, MJ, Banales, JM, Aspichueta, P, Benlloch, S, Rosales, JM, Turnes, J, Romero-Gómez, M. The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis. JOURNAL OF GASTROENTEROLOGY. 2024; 59(7)DOI:10.1007/s00535-024-02098-8. PMID:38619600. IF:5.500(Q1/2D).

01/04/2026 Simvastatin in the prevention of recurrent pancreatitis: a triple-blinded randomised clinical trial (the SIMBA trial)

Guilabert, L, Cárdenas-Jaén, K, Vaillo-Rocamora, A, Ruiz-Rebollo, ML, Bolado-Concejo, F, Martínez-Moneo, E, Rivera-Irigoin, R, Martin-Mateos, R, García-Rayado, G, López-Serrano, A, Martí-Marqués, E, Rodríguez-Oballe, JA, Francisco-González, M, Jiménez-Moreno, MA, Cañamares-Orbís, P, Concepción-Martín, M, Pascual-Moreno, I, Del Val, A, Lauret-Braña, E, Sánchez-Marin, C, Del Pozo-García, AJ, Ledro-Cano, D, Zapater, P, Núñez-Otero, J, Bernal-Luján, L, Singh, VK, Papachristou, G, Garg, PK, Wu, BU, Mehta, RM, de-Madaria, E. Simvastatin in the prevention of recurrent pancreatitis: a triple-blinded randomised clinical trial (the SIMBA trial). Lancet Gastroenterology & Hepatology. 2026; 11(4)DOI:10.1136/gutjnl-2025-337154. PMID:41482454. IF:38.600(Q1/1D).

01/08/2026 Current insights on urinary catheter securement using adhesives in ICU patients

Calpe-Damians, N, Llaurado-Serra, M. Current insights on urinary catheter securement using adhesives in ICU patients. Intensive and Critical Care Nursing. 2026; 95DOI:10.1016/j.iccn.2026.104427. PMID:42019368. IF:4.700(Q1/1D).

01/05/2026 Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration

Dingemans, AMC, Opitz, I, Brunelli, A, Remon, J, Hendriks, LE, Edwards, J, Faivre-Finn, C, Reguart, N, Smit, EF, Levy, A, Sanchez-Lorente, D, Trujillo, JC, Filippi, AR, Stathopoulos, K, Blum, TG, Guckenberger, M, Popat, S, De Angelis, R, Hofman, P, von der Thüsen, J, Hartemink, KJ, Petersen, RH, Ruffini, E, Dickhoff, C, Houda, I, Prisciandaro, E, De Ruysscher, D, Derks, J, Bahce, I, Mariolo, A, Besse, B, Xenophontos, E, Levra, NG, van Schil, P, Brandao, M, Berghmans, T. Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration. Lancet Respiratory Medicine. 2026; 14(5)DOI:10.1016/S2213-2600(26)00051-2. PMID:41895314. IF:32.800(Q1/1D).

01/04/2026 Smoking, Colchicine, and Postoperative Outcomes in Thoracic Surgery: Post Hoc Analysis of the COP-AF Randomized Controlled Trial (vol 9, pg 860, 2025)

Ofori, S, Wang, MK, Popova, E, McIntyre, WF, Chan, MT, Sessler, DI, Giulia, V, Warwas, M, Balasubramanian, K, Tandon, V, Finley, C, Anna, GT, Cata, J, Srinathan, S, Reimer, C, McLean, S, Trujillo, JC, Fleischmann, E, Voltolini, L, Cruz, P, Maziak, DE, Gutiérrez-Soriano, L, Amir, M, Bossard, M, Wang, CY, Devereaux, PJ, Conen, D. Smoking, Colchicine, and Postoperative Outcomes in Thoracic Surgery: Post Hoc Analysis of the COP-AF Randomized Controlled Trial (vol 9, pg 860, 2025). Cjc Open. 2026; 8(4)DOI:10.1016/j.cjco.2026.01.001. PMID:42007188. IF:(Q/D).

01/12/2025 Custom-made dynamic 3-dimensional-printed prostheses for chest wall reconstruction: A multicenter study

Cano, JR, Jiménez, U, Trujillo, JC, Galbis, JM, Monopoli, D, Pérez, D, Fra-Fernández, S, Uribe-Etxebarria, N, Martínez E., Estors, M, Mentado, B, Muñoz-Molina, GM, Medina, R, Lorenzo, M, Hernandez-Ferrandez, J, Tavárez, W, Leung, M, Moreno-Mata, N. Custom-made dynamic 3-dimensional-printed prostheses for chest wall reconstruction: A multicenter study. Jtcvs Techniques. 2025; 34DOI:10.1016/j.xjtc.2025.09.010. PMID:41368406. IF:(Q/D).